1. Home
  2. GORO vs SER Comparison

GORO vs SER Comparison

Compare GORO & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

N/A

Current Price

$1.46

Market Cap

250.9M

ML Signal

N/A

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

N/A

Current Price

$1.60

Market Cap

19.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GORO
SER
Founded
1998
2017
Country
United States
United States
Employees
N/A
13
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
250.9M
19.4M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
GORO
SER
Price
$1.46
$1.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$1.75
$13.00
AVG Volume (30 Days)
2.4M
98.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,726,000.00
N/A
Revenue This Year
$9.04
$134.46
Revenue Next Year
$93.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$1.47
52 Week High
$1.87
$7.92

Technical Indicators

Market Signals
Indicator
GORO
SER
Relative Strength Index (RSI) 49.24 37.12
Support Level $1.27 $1.53
Resistance Level $1.75 $1.86
Average True Range (ATR) 0.10 0.12
MACD -0.04 0.02
Stochastic Oscillator 32.00 32.05

Price Performance

Historical Comparison
GORO
SER

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: